Show simple item record

dc.contributor.authorGopal, A. K.
dc.contributor.authorPopat, R.
dc.contributor.authorMattison, R. J.
dc.contributor.authorMenne, T.
dc.contributor.authorBloor, Adrian
dc.contributor.authorGaymes, T.
dc.contributor.authorKhwaja, A.
dc.contributor.authorJuckett, M.
dc.contributor.authorChen, Y.
dc.contributor.authorCotter, M. J.
dc.contributor.authorMufti, G. J.
dc.date.accessioned2022-01-11T12:00:05Z
dc.date.available2022-01-11T12:00:05Z
dc.date.issued2021en
dc.identifier.citationGopal AK, Popat R, Mattison RJ, Menne T, Bloor A, Gaymes T, et al. A Phase I trial of talazoparib in patients with advanced hematologic malignancies. Int J Hematol Oncol. 2021;10(3):Ijh35.en
dc.identifier.pmid34840720en
dc.identifier.doi10.2217/ijh-2021-0004en
dc.identifier.urihttp://hdl.handle.net/10541/624951
dc.titleA Phase I trial of talazoparib in patients with advanced hematologic malignanciesen
dc.typeArticleen
dc.contributor.departmentDivision of Medical Oncology, Department of Medicine, University of Washington, Seattle, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USAen
dc.identifier.journalInternational Journal of Hematologic Oncologyen
dc.description.noteen]
refterms.dateFOA2022-04-13T08:02:50Z


Files in this item

Thumbnail
Name:
34840720.pdf
Size:
434.8Kb
Format:
PDF
Description:
From EPMC

This item appears in the following Collection(s)

Show simple item record